EANM enabling guide: how to improve the accessibility of clinical dosimetry.

Détails

Ressource 1Télécharger: 37086275_BIB_CFE88D971A60.pdf (466.55 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_CFE88D971A60
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
EANM enabling guide: how to improve the accessibility of clinical dosimetry.
Périodique
European journal of nuclear medicine and molecular imaging
Auteur⸱e⸱s
Gear J., Stokke C., Terwinghe C., Gnesin S., Sandström M., Tran-Gia J., Cremonesi M., Cicone F., Verburg F., Hustinx R., Giovanella L., Herrmann K., Gabiña P.M.
ISSN
1619-7089 (Electronic)
ISSN-L
1619-7070
Statut éditorial
Publié
Date de publication
06/2023
Peer-reviewed
Oui
Volume
50
Numéro
7
Pages
1861-1868
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Dosimetry can be a useful tool for personalization of molecular radiotherapy (MRT) procedures, enabling the continuous development of theranostic concepts. However, the additional resource requirements are often seen as a barrier to implementation. This guide discusses the requirements for dosimetry and demonstrates how a dosimetry regimen can be tailored to the available facilities of a centre. The aim is to help centres wishing to initiate a dosimetry service but may not have the experience or resources of some of the more established therapy and dosimetry centres. The multidisciplinary approach and different personnel requirements are discussed and key equipment reviewed example protocols demonstrating these factors are given in the supplementary material for the main therapies carried out in nuclear medicine, including [ <sup>131</sup> I]-NaI for benign thyroid disorders, [ <sup>177</sup> Lu]-DOTATATE and <sup>131</sup> I-mIBG for neuroendocrine tumours and [ <sup>90</sup> Y]-microspheres for unresectable hepatic carcinoma.
Mots-clé
Humans, Radiometry/methods, Iodine Radioisotopes, Neuroendocrine Tumors/diagnostic imaging, Neuroendocrine Tumors/radiotherapy, 3-Iodobenzylguanidine, Dosimetry, Molecular radiotherapy, Nuclear medicine, Optimisation, Quantitative imaging, SPECT
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/05/2023 9:44
Dernière modification de la notice
08/08/2024 6:40
Données d'usage